Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Explore budgeting tips that drive financial success through precise allocations, goal alignment, and disciplined spending controls.
22,313 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
A biotech growth stock has surged 70% this year as it heads into pivotal phase 3 data and regulatory steps. Here’s wh...
Choosing between two healthcare giants comes down to balance: steady income or longer-term growth. This guide dives i...
Three years can change a company’s story. Explore the signals that will determine MercadoLibre's path, focusing on fi...
Retirees watch inflation closely, especially when planning for 2027. This article breaks down what could drive a hist...
Two consumer-facing stocks sit at a crossroads: GameStop is tightening its turnaround with a leaner footprint, while ...
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
In 2026, you can build real passive income with smart, practical plans. This guide breaks down ideas that work, plus ...
SpaceX is changing how index funds think about new entrants. This guide breaks down the mechanics, shows real example...
A practical, reader-friendly guide to what to expect in evaxion (evax) 2025 earnings. Learn the drivers, read the cal...
Understanding runway growth (rway) earnings helps you assess whether a young company can sustain momentum. Learn key ...
The Starship launch is drawing global attention, but SpaceX remains private. This guide explains what that means for ...